Vertex Pharmaceuticals Inc [VRTX]
$174.13 3.96 (2.22%)
Market Cap 45.33 Billion
Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, and Symdeko for cystic fibrosis, in addition to several pipeline candidates targeting this market. Vertex's pipeline also includes therapies for cancer, pain, inflammatory diseases, influenza, and other rare diseases.
EPS 1.05 P/E Ratio 20.79
Previous Earnings Tue, Apr 30, 2019
Latest Earnings Wed, Jul 31, 2019 (In 10 days)
Pay Date --
|Symbol||Price||Day %||YTD %|
This list of trending stocks may change throughout the trading day.